首页> 外国专利> NOVEL THERANOSTIC PLATFORM FOR TARGETED CANCER THERAPY AND DRUG DELIVERY MONITORING

NOVEL THERANOSTIC PLATFORM FOR TARGETED CANCER THERAPY AND DRUG DELIVERY MONITORING

机译:用于靶向癌症治疗和药物输送监测的新型治疗平台

摘要

A compound that includes a quaterrylene dye moiety as core, and a dendrimeric shell. For example, the compound may comprise at least four dendronized polyamides covalently attached to a quaterrylene dye. Also disclosed is a compound, or a pharmaceutically acceptable salt or ester thereof, comprising A(G)x, wherein:A comprises a quaterrylene dye;G comprises at least one functionalized dendrimeric structure; andx is 2 to 16.The compounds may be used for in methods for monitoring a therapeutic or diagnostic agent in a subject, or for treating a subject by administering the compound to the subject.
机译:一种化合物,其包括季戊四烯染料部分作为核和树枝状壳。例如,该化合物可以包含至少四个共价附接到季戊四烯染料的树枝状聚酰胺。还公开了包含A(G) x 的化合物或其药学上可接受的盐或酯,其中: A包含季戊四烯染料; G包含至少一个官能化的树枝状结构;并且 x为2到16。所述化合物可用于在受试者中监测治疗剂或诊断剂的方法中,或用于通过将化合物施用于受试者来治疗受试者的方法。

著录项

  • 公开/公告号US2014037542A1

    专利类型

  • 公开/公告日2014-02-06

    原文格式PDF

  • 申请/专利权人 MINGFENG BAI;PIN SHAO;

    申请/专利号US201313955944

  • 发明设计人 MINGFENG BAI;PIN SHAO;

    申请日2013-07-31

  • 分类号A61K49/00;

  • 国家 US

  • 入库时间 2022-08-21 16:01:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号